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cross-resistance to other antibiotic classes. CTZR may 
be due to AmpC or extended spectrum P-lactamases 
(ESBL). ESBL (+) GNB have been noted with in- 
creasing frequency in acute care and in outbreaks in NH. 
In our NH from 1995-97, rates of CTZR in clinical 
isolates were 10%. From ll/OO-3/02, screening of 1042 
GNB clinical isolates from our attached hospital yielded 
(8%) CTZR and 21 (2%) ESBL (+) isolates. Little is 
known about endemic colonization rates with CTZR 
GNB or ESBL in NH. Admissions to our NH were 
prospectively screened for GNB, CTZR, and ESBL 
every 2 weeks. Oropharynx, perineum, and wounds 
swabs were plated on MacConkey (Mac) agar. GNB 
were screened for CTZR on Mac+CTZ agar. Rectal 
swabs were plated directly on Mac+CTZ agar. CTZR 
GNB were screened for ESBL by double disk diffusion 
using CTZ or cefotaxime alone or in combination with 
clavulanate. 65 patients (pts) were screened on multiple 
occasions. 87 GNB isolates were detected in 38 pt (58%). 
GNB were found more often in pts with wounds, 
p=O.O5. Perineum (82%) and oropharynx (32%) were 
the most common sites of GNB colonization. Escherichia 
coli, Pseudomonas, Klebsiella, Proteus, Enterobacter, and 
Citrobacter were the most common genera isolated. 13 
(20%) of colonized pt had CTZR GNB, most commonly 
Pseudomonas or Enterobacter. Four pt (6%) had an 
ESBL (+) strain. No association with GNB, CTZR, or 
ESBL carriage could be made with age, declining func- 
tional status, increased length of stay, presence of devices, 
or co-morbid illness. Rates of colonization with ESBL 
producing CTZR GNB in NH may approach rates 
described in hospitals. 
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Background: Carbapenems and quinolones have a 
broad spectrum of antibacterial activity, and they are 
most potent agents used for chemotherapy of infectious 
disease caused by Gram-negative rods. Recently, how- 
ever, the emergence of the multidrug resistant Pseudo- 
monas aeruginosa (MDRP) is of utmost clinical concern, 
little information in regard to the distribution of MDRP 
in hospitals and the clinical characteristics of infected 
patients is available. To address this, we reviewed 
retrospectively the clinical charts of the patients infected 
with MDRP to clarify their clinical characteristics and 
significance in the hematological ward and screened the 
resistance gene. 
Methods: This study was conducted at Saitama Medical 
School Hospital in Saitama, Japan. We examined the 
antimicrobial susceptibilities of clinical isolates of 
MDRP, that were resistant to imipenem, amikacin, and 
ciprofloxacin, in hematological ward between 1999 
and 2001. Then we screened for the blarMp gene, which 
produced the metallo-beta-lactamase IMP-l. 
Results: A total of 16 isolated were detected in hema- 
tological disease patient in four years. We evaluated the 
clinical characteristics of 16 patients. MDRP organisms 
were isolated from stool sample (43.8%) urinary sample 
(25.0%) and respiratory sample (12.5%). Furthermore, 
the iatrogenic risk factor were anti-neoplastic agents 
(87.5%) IVH catheter (50.0%) steroids (43.8%), 
urinary catheter (43.8%). The clinical significance of 
detected MDRP was infection (25.0%) and colonization 
(68.8%). Infection was thought to have been the possible 
cause of death in 3 patients: clinical sepsis in two patient 
and terminal pneumonia in a patient. All isolations were 
detected the bluIMp gene. 
Conclusions MDRP is much detected from admini- 
stration of anti-neoplastic patients in hematological 
ward. Infection-related death was more frequent in case 
MDRP were detected in blood samples. 
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Background: Efforts to ensure provision of microbio- 
logically safe potable water for immunocompromised 
(IC) patients have focused on the elimination of C. 
parvum, although potable water may also contain oppor- 
tunistic pathogens such as Gram-negative environmental 
bacteria. In the UK, official guidelines advise patients 
with compromised T-cell function to drink only cooled 
boiled water (CBW). The provision of large quantities 
of CBW at one hospital in Leeds was identified as 
presenting a safety risk for health care personnel and 
safer alternatives were sought. 
Methods: A survey of provision of drinking water for IC 
patients throughout the Leeds Teaching Hospitals Trust 
was conducted. A range of options for potable water 
provision was then considered-CBW, carbonated and 
non-carbonated bottled water, sterile bottled water 
(SBW), mains water direct from the faucet (MW) and 
water filtered using commercial end-line filters (FW). 
The following criteria were examined: (1) microbio- 
logical safety, (2) end-user acceptability, (3) logistical 
considerations and (4) cost. 
Results: Marked disparities in practice were identified, 
e.g. some units that provided CBW used sterile jugs, 
whereas others did not. Other areas provided only 
MW. Provision of CBW to HIV positive patients com- 
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promised patient confidentiality, as it allowed identi- 
fication of these individuals. The significant differences 
in practice prompted a survey of 11 other hospitals 
within the Yorkshire region, which revealed that these 
disparities were not confined to our organisation. CBW 
was rejected on grounds of preparation time, staff safety 
and patient confidentiality. Non-carbonated bottled 
water was rejected because of poor microbiological 
quality. Carbonated water, although microbiologically 
safer, was not acceptable to patients with chemotherapy- 
associated mucositis. SBW, as with other bottled water 
types, was relatively expensive and had poor organo- 
leptic quality. There were also logistical problems in 
delivery to, and storage of bottles on, units citywide. FW 
met criteria 1 to 3 and compared favourably with bottled 
water in terms of cost. FW has now been accepted as the 
preferred method of providing water to IC patients in 
our organisation 
Conclusion: Striking disparities in provision of potable 
water for IC patients as identified locally and regionally 
are of concern and we recommend that national 
guidelines are developed to ensure that IC patients 
receive safe drinking water. We would advocate that 
consideration should be given to filtered water in the 
drawing up of such guidelines 
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Objectives: Bacteremia due to Escherichia coli (ECB) is 
still the most common causes of infection in patients 
with hematologic malignancies in our center. 
Methods: The clinical characteristics of ECB in 2001 
were evaluated retrospectively. The results were com- 
pared with a control group with vancomycin resistant 
enterococci bacteremia (VREB). 
Results: Total 85 patients experienced the ECB in 
the year of 2001. Age, sex ratio, SAPS11 score were 
not different statistically from each other group. The 
Underlying diseases in ECB were acute myloid leu- 
kemia (AML) (63.5%) acute lymphoblastic leukemia 
(ALL) (34.1%) and the type of therapy were induction 
or reinduction chemotherapy(37.7%), consolidation 
chemotherapy (35.3%) allogeneic bone marrow trans- 
plant (BMT) (13.0%) autologous BMT (10.6%). The 
underlying diseases and type of therapy were different 
from each other group (P<O.OOl, .04). Neutropenia was 
more prevalent in the ECB group (P=O.OOl), but 
neutropenia and hospitalization were more prolonged in 
the VREB group (P= .006, .006). Co-infection was more 
common in the VREB group (P<O.OOl). Twenty eight 
(32.9%) of patients were presented with septic shock in 
ECB group compared with 14.3% in VREB (P=O.O9). 
Acute mortality rate associated with ECB and VREB 
were 9.4% and 71.4% (PcO.001). Most E. coli isolates 
were susceptible to ceftazidime (lOO%), cefepime 
(100%) amikacin (94.1%) and at least one antibiotics 
used empirically were susceptible. But, 94.1% of E. coli 
were resistant to ciprofloxacin, the prophylactic 
antibiotics for gut decontamination. 
Conclusions: In spite of neutropenia and septic shock, 
most patients of ECB were recovered. Persistence of 
neutropenia, co-infection with fungus were associated 
with high mortality rate. 
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Background: This study was to investigate the etiologic 
organisms, risk factors, and other infectious features of 
septic shock in the hematology and oncology patients 
with neutropenic fever. 
Methods: We reviewed medical record of 671 patients 
receiving chemotherapy or hematopoietic stem cell trans- 
plantation (HSCT) at Catholic HSCT Center from Jan 
1998 to Dee 1999, and found out 457 patients developing 
neutropenic fever. Out of them, 39 patients developing 
septic shock as initial manifestation were enrolled into 
case group and age/sex matched 267 patients without 
hypotension were enrolled into control group. 
Results: There were 177 men and 129 women, with a 
median age of 31 years. Overall incidence of septic shock 
was 8.5%. Most common underlying disease of the two 
groups was acute leukemia. Infections were classified as 
31 MDI, 4 CDI, and 4 UF in the case group, whereas the 
control group had 105, 112,49, respectively (P<O.OOl). 
Thirty-seven microorganisms were isolated as causative 
agents in 31 MD1 of the case group. They were 5 gram- 
positive bacteria (13.5%) and 29 gram-negatives 
(78.3%). Whereas 137 microorganisms isolated in the 
MD1 of the control group were 63 gram-positive 
bacteria (45.9%) and 64 gram-negatives (46.7%). 
Relative risk for the gram-negative bacterial infection in 
the case group was 7.20 (P<O.OOl). Escherichia coli was 
the most common organism in the two groups (51.3% vs 
27.7%, P<O.OOl). Most common infection sites were 
respiratory tract in the case group and gastrointestinal 
tract in the control group. And the respiratory tract 
infection was significantly more frequent in the case 
group (P=O.O38). Mean leukocyte count at the onset of 
fever was 207/mm3 and 355/mm3 (P=O.O27) and mean 
duration of total febrile day was 12.3 days and 7.8 days, 
respectively (P=O.OOl). On multivariate analysis, only 
